Lennox, Ryan Christopher

Insider profile

Performance

Overall performance

Performance over holding periods
30 days 90 days 120 days
Average return 10% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Lennox, Ryan Christopher's trades of HLS Therapeutics Inc's stock


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
451.08
Quantity 80,454 -44.3%
Value CA$3,644,993
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-09-08 2026-09-08 B Purchase
80,454 -44.3%
451.08
CA$3,644,993
80,454 -44.3% 451.08 CA$3,644,993